1. Home
  2. BDSX vs SIGA Comparison

BDSX vs SIGA Comparison

Compare BDSX & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biodesix Inc.

BDSX

Biodesix Inc.

N/A

Current Price

$26.63

Market Cap

276.2M

Sector

Health Care

ML Signal

N/A

Logo SIGA Technologies Inc.

SIGA

SIGA Technologies Inc.

N/A

Current Price

$3.20

Market Cap

223.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BDSX
SIGA
Founded
2005
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
276.2M
223.8M
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
BDSX
SIGA
Price
$26.63
$3.20
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$32.50
N/A
AVG Volume (30 Days)
122.8K
684.4K
Earning Date
05-04-2026
05-05-2026
Dividend Yield
N/A
13.24%
EPS Growth
N/A
N/A
EPS
N/A
0.13
Revenue
$88,499,000.00
N/A
Revenue This Year
$25.26
N/A
Revenue Next Year
$19.15
$224.81
P/E Ratio
N/A
$25.31
Revenue Growth
24.08
N/A
52 Week Low
$0.35
$2.83
52 Week High
$31.31
$9.45

Technical Indicators

Market Signals
Indicator
BDSX
SIGA
Relative Strength Index (RSI) 55.53 51.74
Support Level $19.26 $2.92
Resistance Level $31.31 $4.84
Average True Range (ATR) 2.56 0.14
MACD -0.18 0.05
Stochastic Oscillator 51.91 70.73

Price Performance

Historical Comparison
BDSX
SIGA

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

About SIGA SIGA Technologies Inc.

SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.

Share on Social Networks: